Niloufar Farzan

Niloufar Farzan

Auto-generated profile, based on publicly available information

Niloufar Farzan

Iranian Evidence Based Medicine Center of Excellence, Tabriz University of Medical Sciences, Tabriz, Iran

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
NFNiloufar Farzan
Niloufar Farzan
SVSusanne J.H. Vijverberg
Susanne J.H. Vijverberg
MKMichael Kabesch
Michael Kabesch
PSPeter J. Sterk
Peter J. Sterk
Anke H. Maitland-van der ZeeAnke H. Maitland-van der Zee
Anke H. Maitland-van der Zee

9 June 2018 in Allergy
Verified
Journal Article
Open access
PDF file
NFNiloufar Farzan
Niloufar Farzan
SVSusanne J.H. Vijverberg
Susanne J.H. Vijverberg
NHNatalia Hernandez-Pacheco
Natalia Hernandez-Pacheco
EBElisabeth H D Bel
Elisabeth H D Bel
VBVojko Berce
Vojko Berce
Anke H. Maitland-van der ZeeAnke H. Maitland-van der Zee
Anke H. Maitland-van der Zee

9 October 2021 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
AMAta Mahmoodpoor
Ata Mahmoodpoor
AFAfsaneh Farjami
Afsaneh Farjami
NFNiloufar Farzan
Niloufar Farzan
HHHamed Hamishehkar
Hamed Hamishehkar
PAparina asgharian
parina asgharian
HHHadi Hamishehkar
Hadi Hamishehkar
Purpose: Sepsis and SIRS encompass various problems throughout the body, and two of its major problems are the creation of oxidative substances in the body and decrease of the body's antioxidant capacity to deal with the stress and organ damage. Optimal Enteral Nutrition (EN) fortified with antioxidant or immunomodulator amino acid is a hot topic concerning sepsis in the critical care setting. Taurine plays a protective role as an antioxidant in cells that is likely to have a protective role in inflammation and cytotoxicity. Methods: In the present study, 20 septic patients and 20 healthy volunteers were enrolled. The blood and plasma taurine levels of the patients on days 1, 3 and 7 were measured. Blood and plasma taurine level and the correlation between them, organ failure, and severity of the disease were assessed. Results: Taurine concentrations in the plasma of the septic patients were significantly lower than control group, and the whole blood concentrations were significantly higher than those of the control group (P<0.001). There was not a significant correlation between the blood and plasma taurine levels in control and septic patients. In addition, there was not any correlation between the severity of the disease, organ failure, mortality, and plasma as well as the blood concentration of taurine. Conclusion: In septic patients, taurine concentration in plasma and blood are low and high, respectively. These concentrations are not linked to each other and not associated with the patients’ outcome, and the disease severity, and organ failure.